A startling milestone has been reached in Florida’s war against the invasive Burmese pythons eating their way across the Everglades.

We opt for topdown recursive decomposition ... segmentation proposed in this work. We also demonstrate its application for fine-grained part refinements in image-to-shape reconstruction. Our code has ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, there’s been a lot of discussion lately about how the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

How do you, a Python developer, deal with working on a system that has either undependable network connectivity or none at all? The good news is, you can make it work, provided you have two basic ...

Indeed, I believe the value of the company lies in its Recursion OS and their drug discovery and development platform (see image below). Recursion’s innovative drug discovery process integrates ...

“Once it realized we weren’t a threat, [the snake] proceeded to finish its meal. And it’s hard to describe ... of this drives home the importance of the removal work that Bartoszek and other python ...

In addition, Recursion will also explore making some of its AI models available on Google Cloud. The enriched partnership supports Recursion's ongoing effort to tackle the biopharmaceutical ...

The artificial intelligence (AI) revolution continues to tout developing drugs faster and at lower cost, but are we there yet? On October 2nd, the FDA cleared an investigational new drug (IND ...

To overcome these drawbacks, this work presents ... capabilities of the recursive GRU models are especially helpful for detecting patterns and anomalies in security-related cloud logs, as evidenced by ...

You can reach Allison on Signal at AllisonDeAngelis.01. Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that, while a success on paper ...